Laboratory automation

Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech

Retrieved on: 
Wednesday, April 24, 2024

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products.

Key Points: 
  • Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products.
  • By combining powerful automation with the Parse Evercode platform, customers will have unprecedented access to high-throughput single cell sequencing, enabling them to rapidly generate insights for large-scale studies.
  • As key providers in the new Laboratory Automation Provider Program, Hamilton, Opentrons, and SPT Labtech will each collaborate with Parse to automate Parse’s Evercode Whole Transcriptome and Whole Transcriptome Mega workflows on their respective liquid handling platforms.
  • By joining with some of the industry's top automation providers, we are giving customers more extensive choices,” said Parse Biosciences co-founder and CEO Alex Rosenberg.

Labroots Announces its 8th Annual Laboratory Automation Virtual Event, Scheduled on March 20, 2024

Retrieved on: 
Thursday, March 14, 2024

YORBA LINDA, Calif., March 14, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website, offering premier, interactive virtual events and webinars, is delighted to host its 8th annual Laboratory Automation online event on March 20, 2024. This free event brings together thousands of research scholars, scientists, and laboratory personnel from leading academic and industry institutions under a virtual roof to explore scientific disciplines with sessions spanning microfluidic and microscale technologies for automation, automation and emerging methods, lab automation with cutting-edge tools, LIMS and other automation software, and analytics for high-throughput and high content assays.

Key Points: 
  • YORBA LINDA, Calif., March 14, 2024 /PRNewswire-PRWeb/ -- Labroots , the leading scientific social networking website, offering premier, interactive virtual events and webinars, is delighted to host its 8th annual Laboratory Automation online event on March 20, 2024.
  • The insightful agenda encompasses leading-edge advancements aimed at automating and accelerating research, and amplifying efficiency in the lab.
  • A lively Q&A session, following the presentation sponsored by Automata titled, "How to Prepare for Lab Automation."
  • Participants can use the official hashtag #LRlabauto to follow the conversation and connect with other members in the Laboratory Automation community!

Society for Laboratory Automation and Screening (SLAS) Selects CytoTronics’ Pixel System for 2024 New Product Award

Retrieved on: 
Tuesday, March 5, 2024

CytoTronics, Inc. , a pioneer of semiconductor-based platforms for discovery in cell biology, is pleased to announce that their Pixel ™ system received the 2024 New Product Award from the Society for Laboratory Automation and Screening (SLAS).

Key Points: 
  • CytoTronics, Inc. , a pioneer of semiconductor-based platforms for discovery in cell biology, is pleased to announce that their Pixel ™ system received the 2024 New Product Award from the Society for Laboratory Automation and Screening (SLAS).
  • Award selection was announced at the SLAS2024 International Conference and Exhibition in Boston, MA on February 6th, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240305158077/en/
    CytoTronics' Pixel™ system received the 2024 New Product Award from the Society for Laboratory Automation and Screening (SLAS).
  • Front-runners are interviewed on-site at the conference by a panel of industry veterans with deep expertise in laboratory automation and screening techniques to determine final award recipients.

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology

Retrieved on: 
Monday, February 12, 2024

Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology.

Key Points: 
  • Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology.
  • The award coincides with the first showing of Depixus’ ground-breaking MAGNA One™ instrument at the conference.
  • View the full release here: https://www.businesswire.com/news/home/20240212670326/en/
    Depixus CEO Gordon Hamilton receives the SLAS2024 Ignite Award from judge Severine Tamas-Lhoustau, CEO of Novoptim.
  • Depixus CEO Gordon Hamilton says, “We’re thrilled to have won this year’s Ignite Award against such stiff competition and congratulate all the other finalists.

Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows

Retrieved on: 
Tuesday, February 6, 2024

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with built-in Parse Evercode™ single cell protocols.

Key Points: 
  • Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with built-in Parse Evercode™ single cell protocols.
  • As part of the agreement, Parse will sell a bundled solution composed of Evercode single cell reagents and an application-enabled INTEGRA Assist Plus instrument directly to customers.
  • As part of the deal, Parse customers will be supported by both the Parse Biosciences and INTEGRA field service and sales teams.
  • The Parse Biosciences team will be presenting a poster on the efficiency gained by integrating the INTEGRA Assist Plus with the Evercode protocols at the Society for Laboratory Automation and Screening (SLAS) conference in Boston February 3-7.

CytoTronics Reveals Pixel System to Monitor Live Cell Function at an Unprecedented Scale for Cell Biology Applications

Retrieved on: 
Monday, February 5, 2024

Pixel assesses live cell function at single-cell resolution, allowing scientists to simultaneously monitor cell viability, morphology, electrophysiology, metabolism, and more while generating electrical ‘images’ with single-cell spatial resolution.

Key Points: 
  • Pixel assesses live cell function at single-cell resolution, allowing scientists to simultaneously monitor cell viability, morphology, electrophysiology, metabolism, and more while generating electrical ‘images’ with single-cell spatial resolution.
  • Pixel delivers simultaneous multi-modal, high-resolution readouts in 96- or 384-well plates, enabling cell monitoring and data collection at unprecedented scale.
  • It’s widely applicable for in vitro cell biology applications including drug discovery, from target validation to toxicology screening.”
    CytoTronics’ early-access program for Pixel Primo empowers cell biologists to unlock applications that were previously inaccessible.
  • The early-access program includes applications for endothelial and epithelial cells, cancer cell biology, mechanism of action/toxicology, stem cell biology, cardiac function, and neural function.

Deepcell Unveils Innovative AI-Powered Single Cell Morphology Data at Leading Scientific Meetings

Retrieved on: 
Thursday, February 1, 2024

In addition, the company announced that its REM-I Platform is a finalist for the New Product Award at SLAS.

Key Points: 
  • In addition, the company announced that its REM-I Platform is a finalist for the New Product Award at SLAS.
  • “We look forward to sharing the tremendous progress we’ve made as a company with the scientific community at these meetings.
  • A year ago, we were presenting our first public datasets at AGBT and attending SLAS for the first time.
  • This year, we have the REM-I Platform in field testing, are presenting substantially more data, and look forward to the full commercialization of our instrument later this year,” said Maddison Masaeli, Ph.D., co-founder and chief executive officer at Deepcell.

Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management

Retrieved on: 
Friday, February 2, 2024

BURLINGTON, Mass., Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.

Key Points: 
  • BURLINGTON, Mass., Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.
  • The Ultra is an innovative evolution stemming from Azenta's well-established and industry-leading automated ultracold system product range.
  • "We are proud to launch the BioArc Ultra, a breakthrough solution that offers countless economic and environmental sustainability benefits to our customers across the sample management landscape," stated Dean Montano, Senior Product Manager for Azenta's Automated Storage Solutions.
  • Azenta undertakes no obligation to update the information contained in this press release.

Auburn Engineering faculty start-up VivoSphere™ nominated for prestigious Ignite Award

Retrieved on: 
Tuesday, January 16, 2024

The New Venture Accelerator company was nominated for the Ignite Award Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition SLAS2024 to be held on February 3-6 in Boston, Massachusetts.

Key Points: 
  • The New Venture Accelerator company was nominated for the Ignite Award Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition SLAS2024 to be held on February 3-6 in Boston, Massachusetts.
  • "We are honored to be nominated for the prestigious Ignite Award and thankful for the extraordinary opportunity it offers us to exhibit on the Innovation AveNEW showcase at SLAS next month," said Tian.
  • This level of detail is impossible to achieve with 2D cultures or current iterations of 3D testing models."
  • To schedule a meeting with VivoSphere during SLAS, please contact Yuan Tian at [email protected] .

Asia-Pacific Laboratory Automation Market Analysis and Forecasts, 2023-2033: Increasing Opportunity for Laboratory Automation in Emerging Economies & Partnerships and Alliances

Retrieved on: 
Tuesday, January 9, 2024

DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The "Asia-Pacific Laboratory Automation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The "Asia-Pacific Laboratory Automation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • Increasing scientific research, testing, and experimentation throughput, accuracy, reproducibility, and efficiency are the aims of laboratory automation.
  • The laboratory automation market in Asia-Pacific has been segmented into multiple product categories, encompassing liquid handling equipment, appliances, accessories, and software.
  • Competitive Strategy: The Asia-Pacific laboratory automation market is a highly fragmented market, with many smaller and private companies constantly entering the market.